You just read:

Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

11 May, 2015, 13:00 BST